SEC Filings | Landos Biopharma

Filing date	Form	Description	View
03/23/23	S-8	Securities offered to employees pursuant to employee benefit plans	0000950170-23-009337.pdf 0000950170-23-009337.rtf 0000950170-23-009337.xls View HTML
03/10/23	8-K	Report of unscheduled material events or corporate event	0001193125-23-067778.pdf 0001193125-23-067778.rtf 0001193125-23-067778.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
03/02/23	4	Statement of changes in beneficial ownership of securities	0001209191-23-014612.pdf 0001209191-23-014612.rtf 0001209191-23-014612.xls View HTML
03/02/23	4	Statement of changes in beneficial ownership of securities	0001209191-23-014626.pdf 0001209191-23-014626.rtf 0001209191-23-014626.xls View HTML
03/02/23	4	Statement of changes in beneficial ownership of securities	0001209191-23-014634.pdf 0001209191-23-014634.rtf 0001209191-23-014634.xls View HTML
03/02/23	4	Statement of changes in beneficial ownership of securities	0001843575-23-000002.pdf 0001843575-23-000002.rtf 0001843575-23-000002.xls View HTML
02/28/23	8-K	Report of unscheduled material events or corporate event	0000950170-23-005215.pdf 0000950170-23-005215.rtf 0000950170-23-005215.xls EX-101.PRE - XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT View HTML
02/14/23	SC 13G/A	An amendment to the SC 13G filing	0001493152-23-005012.pdf 0001493152-23-005012.rtf 0001493152-23-005012.xls View HTML
02/14/23	5	Annual filing director officer or owner of more than ten percent.	0001843575-23-000001.pdf 0001843575-23-000001.rtf 0001843575-23-000001.xls View HTML
01/13/23	8-K	Report of unscheduled material events or corporate event	0000950170-23-000731.pdf 0000950170-23-000731.rtf 0000950170-23-000731.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML

Data provided by Kaleidoscope.